IMPROVED DRUG DELIVERY - A PERSPECTIVE FROM INDUSTRY

被引:0
|
作者
JONES, TM
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:23 / 31
页数:9
相关论文
共 50 条
  • [31] Drug Delivery Using Nanocarriers: Indian Perspective
    Gupta S.
    Kumar P.
    Proceedings of the National Academy of Sciences, India Section B: Biological Sciences, 2012, 82 (Suppl 1) : 167 - 206
  • [32] Chitosan and Its Derivatives for Drug Delivery Perspective
    Sonia, T. A.
    Sharma, Chandra P.
    CHITOSAN FOR BIOMATERIALS I, 2011, 243 : 23 - 53
  • [33] Smart polymers in drug delivery: a biological perspective
    Hunter, A. Christy
    Moghimi, S. Moein
    POLYMER CHEMISTRY, 2017, 8 (01) : 41 - 51
  • [34] Drug formulation and delivery: a UK and Ireland perspective
    Dimitrios Lamprou
    Katie B. Ryan
    Drug Delivery and Translational Research, 2023, 13 : 2057 - 2057
  • [35] LIPOSOMAL DRUG DELIVERY - ADVANTAGES AND LIMITATIONS FROM A CLINICAL PHARMACOKINETIC AND THERAPEUTIC PERSPECTIVE
    FIELDING, RM
    CLINICAL PHARMACOKINETICS, 1991, 21 (03) : 155 - 164
  • [36] Pharmaceutical Perspective in Wearable Drug Delivery Systems
    Tharmatt, Abhay
    Malhotra, Danish
    Sharma, Hamayal
    Bedi, Neena
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2021, 19 (06) : 386 - 401
  • [37] An Industry Perspective on Clinical Drug Safety Risk Management: From Concept to Practice
    Hartford, Craig
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2006, 13 (01): : E22 - E28
  • [38] De novo pediatric development of an antiviral drug product:: A perspective from industry
    Rogers, JM
    DRUG INFORMATION JOURNAL, 1999, 33 (02): : 397 - 405
  • [39] Challenges of drug development in pediatric oncology. A perspective from the pharmaceutical industry
    Capdeville, R.
    EJC SUPPLEMENTS, 2006, 4 (12): : 77 - 77
  • [40] A PHARMACEUTICAL-INDUSTRY PERSPECTIVE ON DRUG LABELING
    ROBINSON, DS
    PSYCHOPHARMACOLOGY BULLETIN, 1994, 30 (01) : 23 - 25